Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine.

Diaz Z, Aguilar-Mahecha A, Paquet ER, Basik M, Orain M, Camlioglu E, Constantin A, Benlimame N, Bachvarov D, Jannot G, Simard MJ, Chabot B, Gologan A, Klinck R, Gagnon-Kugler T, Lespérance B, Samson B, Kavan P, Alcindor T, Dalfen R, Lan C, Chabot C, Buchanan M, Przybytkowski E, Qureshi S, Rousseau C, Spatz A, Têtu B, Batist G.

Mod Pathol. 2013 Nov;26(11):1413-24. doi: 10.1038/modpathol.2013.81. Epub 2013 Jun 7.

2.

Clinical applications of next-generation sequencing in colorectal cancers.

Kim TM, Lee SH, Chung YJ.

World J Gastroenterol. 2013 Oct 28;19(40):6784-93. doi: 10.3748/wjg.v19.i40.6784.

3.

Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies.

Ross JS, Wang K, Rand JV, Sheehan CE, Jennings TA, Al-Rohil RN, Otto GA, Curran JC, Palmer G, Downing SR, Yelensky R, Lipson D, Balasubramanian S, Garcia L, Mahoney K, Ali SM, Miller VA, Stephens PJ.

Am J Surg Pathol. 2014 Feb;38(2):235-8. doi: 10.1097/PAS.0000000000000102.

PMID:
24418857
4.

Next generation sequencing applications in cancer research.

Zhang W, Nykter M, Chen K.

Cancer Lett. 2013 Nov 1;340(2):149-50. doi: 10.1016/j.canlet.2013.05.026. Epub 2013 Jun 11. No abstract available.

PMID:
23764479
5.

Opportunities and methods for studying alternative splicing in cancer with RNA-Seq.

Feng H, Qin Z, Zhang X.

Cancer Lett. 2013 Nov 1;340(2):179-91. doi: 10.1016/j.canlet.2012.11.010. Epub 2012 Nov 27. Review.

PMID:
23196057
6.

Analyzing the cancer methylome through targeted bisulfite sequencing.

Lee EJ, Luo J, Wilson JM, Shi H.

Cancer Lett. 2013 Nov 1;340(2):171-8. doi: 10.1016/j.canlet.2012.10.040. Epub 2012 Nov 28. Review.

7.

Unique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumors as defined by high-density single-nucleotide polymorphism arrays.

Muñoz-Bellvis L, Fontanillo C, González-González M, Garcia E, Iglesias M, Esteban C, Gutierrez ML, Abad MM, Bengoechea O, De Las Rivas J, Orfao A, Sayagués JM.

Mod Pathol. 2012 Apr;25(4):590-601. doi: 10.1038/modpathol.2011.195. Epub 2012 Jan 6.

8.

Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.

Beltran H, Yelensky R, Frampton GM, Park K, Downing SR, MacDonald TY, Jarosz M, Lipson D, Tagawa ST, Nanus DM, Stephens PJ, Mosquera JM, Cronin MT, Rubin MA.

Eur Urol. 2013 May;63(5):920-6. doi: 10.1016/j.eururo.2012.08.053. Epub 2012 Sep 5.

9.

Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.

Tabone T, Abuhusain HJ, Nowak AK; Australian Genomics and Clinical Outcome of Glioma (AGOG) Network, Erber WN, McDonald KL.

J Clin Pathol. 2014 Jul;67(7):550-5. doi: 10.1136/jclinpath-2014-202173. Epub 2014 Apr 2.

PMID:
24695838
10.

Cancer heterogeneity and "the struggle for existence": diagnostic and analytical challenges.

Horswell S, Matthews N, Swanton C.

Cancer Lett. 2013 Nov 1;340(2):220-6. doi: 10.1016/j.canlet.2012.10.031. Epub 2012 Nov 8. Review.

PMID:
23142290
11.

The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.

Takatsuno Y, Mimori K, Yamamoto K, Sato T, Niida A, Inoue H, Imoto S, Kawano S, Yamaguchi R, Toh H, Iinuma H, Ishimaru S, Ishii H, Suzuki S, Tokudome S, Watanabe M, Tanaka J, Kudo SE, Mochizuki H, Kusunoki M, Yamada K, Shimada Y, Moriya Y, Miyano S, Sugihara K, Mori M.

Ann Surg Oncol. 2013 Apr;20(4):1395-402. doi: 10.1245/s10434-012-2657-z. Epub 2012 Sep 14.

PMID:
22976378
12.

Specific genomic aberrations in primary colorectal cancer are associated with liver metastases.

Bruin SC, Klijn C, Liefers GJ, Braaf LM, Joosse SA, van Beers EH, Verwaal VJ, Morreau H, Wessels LF, van Velthuysen ML, Tollenaar RA, Van't Veer LJ.

BMC Cancer. 2010 Dec 2;10:662. doi: 10.1186/1471-2407-10-662.

13.

Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses.

Ellis M, Davis N, Coop A, Liu M, Schumaker L, Lee RY, Srikanchana R, Russell CG, Singh B, Miller WR, Stearns V, Pennanen M, Tsangaris T, Gallagher A, Liu A, Zwart A, Hayes DF, Lippman ME, Wang Y, Clarke R.

Clin Cancer Res. 2002 May;8(5):1155-66.

14.

Comprehensive genome sequencing of the liver cancer genome.

Nakagawa H, Shibata T.

Cancer Lett. 2013 Nov 1;340(2):234-40. doi: 10.1016/j.canlet.2012.10.035. Epub 2012 Nov 8. Review.

PMID:
23142287
15.

Distinctive Spatiotemporal Stability of Somatic Mutations in Metastasized Microsatellite-stable Colorectal Cancer.

Jesinghaus M, Wolf T, Pfarr N, Muckenhuber A, Ahadova A, Warth A, Goeppert B, Sers C, Kloor M, Endris V, Stenzinger A, Weichert W.

Am J Surg Pathol. 2015 Aug;39(8):1140-7. doi: 10.1097/PAS.0000000000000423.

PMID:
25786087
16.

Costs and effectiveness of genomic testing in the management of colorectal cancer.

Goldstein DA, Shaib WL, Flowers CR.

Oncology (Williston Park). 2015 Mar;29(3):175-83. Review.

17.

Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin.

Rosenwald S, Gilad S, Benjamin S, Lebanony D, Dromi N, Faerman A, Benjamin H, Tamir R, Ezagouri M, Goren E, Barshack I, Nass D, Tobar A, Feinmesser M, Rosenfeld N, Leizerman I, Ashkenazi K, Spector Y, Chajut A, Aharonov R.

Mod Pathol. 2010 Jun;23(6):814-23. doi: 10.1038/modpathol.2010.57. Epub 2010 Mar 26.

18.

Personalized oncology: recent advances and future challenges.

Kalia M.

Metabolism. 2013 Jan;62 Suppl 1:S11-4. doi: 10.1016/j.metabol.2012.08.016. Epub 2012 Sep 19. Review.

PMID:
22999010
19.

Beyond microRNA--novel RNAs derived from small non-coding RNA and their implication in cancer.

Martens-Uzunova ES, Olvedy M, Jenster G.

Cancer Lett. 2013 Nov 1;340(2):201-11. doi: 10.1016/j.canlet.2012.11.058. Epub 2013 Jan 29. Review.

20.

Cancer omics: from regulatory networks to clinical outcomes.

Tang B, Hsu PY, Huang TH, Jin VX.

Cancer Lett. 2013 Nov 1;340(2):277-83. doi: 10.1016/j.canlet.2012.11.033. Epub 2012 Nov 29. Review.

PMID:
23201140

Supplemental Content

Support Center